We are delighted to welcome Professor Khalid Shah (MS, PhD) from Harvard Medical School for an upcoming seminar exploring cutting-edge advances in cancer immunotherapy.
Professor Shah is the Founder and Director of the Center for Stem Cell and Translational Immunotherapy (CSTI) and a Principal Faculty member of the Harvard Stem Cell Institute. He is internationally recognised for pioneering translational cell therapies, including the development of gene-edited and engineered cellular approaches to treat cancer. [Shah Khali…April 2026 | Word]
In this talk, Professor Shah will present his latest research on innovative strategies that combine cellular immunotherapy with the gut microbiome to reprogram cancer immunity. His work has redefined how engineered cells can be used therapeutically—including groundbreaking approaches that repurpose cancer cells themselves to fight disease. [Shah Khali…April 2026 | Word]
Professor Shah’s research has received global attention and has been featured by major outlets including the BBC, CNN, Scientific American, and The New York Times. He has delivered over 300 invited talks worldwide and is widely recognised for his contributions to innovation and clinical translation in oncology. [Shah Khali…April 2026 | Word]
A prolific innovator and entrepreneur, he holds multiple patents, has founded biotech companies focused on translating cell therapies into clinical practice, and has received numerous awards for research excellence, mentorship, and impact in the field. [Shah Khali…April 2026 | Word]
This seminar will provide valuable insights into the future of cancer treatment and the transformative potential of engineered cell-based therapies.